201 related articles for article (PubMed ID: 35716258)
21. Intravitreally Injected HCmel12 Melanoma Cells Serve as a Mouse Model of Tumor Biology of Intraocular Melanoma.
Kilian MM; Loeffler KU; Pfarrer C; Holz FG; Kurts C; Herwig MC
Curr Eye Res; 2016; 41(1):121-8. PubMed ID: 25658144
[TBL] [Abstract][Full Text] [Related]
22. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
23. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
24. Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma.
Sabazade S; Gill V; Herrspiegel C; Stålhammar G
J Cancer Res Clin Oncol; 2022 Mar; 148(3):587-597. PubMed ID: 34775516
[TBL] [Abstract][Full Text] [Related]
25. Density of PAS positive patterns in uveal melanoma: Correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasis.
Stålhammar G; See TRO; Phillips SS; Grossniklaus HE
Mol Vis; 2019; 25():502-516. PubMed ID: 31588174
[TBL] [Abstract][Full Text] [Related]
26. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
[TBL] [Abstract][Full Text] [Related]
27. Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas.
Stenzel M; Tura A; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Lüke J
Clin Exp Ophthalmol; 2016 Jul; 44(5):400-9. PubMed ID: 26590370
[TBL] [Abstract][Full Text] [Related]
28. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
[TBL] [Abstract][Full Text] [Related]
29. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization.
Zheng C; Qiu Y; Zeng Q; Zhang Y; Lu D; Yang D; Feng J; Yan X
Int J Biochem Cell Biol; 2009 Nov; 41(11):2163-72. PubMed ID: 19782948
[TBL] [Abstract][Full Text] [Related]
30. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
[TBL] [Abstract][Full Text] [Related]
31. Synergistic killing effect between vorinostat and target of CD146 in malignant cells.
Ma X; Liu J; Wu J; Yan X; Wu P; Liu Y; Li S; Tian Y; Cao Y; Chen G; Meng L; Xu G; Wang S; Lu Y; Ma D; Zhou J
Clin Cancer Res; 2010 Nov; 16(21):5165-76. PubMed ID: 20884621
[TBL] [Abstract][Full Text] [Related]
32. Novel mouse model for primary uveal melanoma: a pilot study.
Süsskind D; Hurst J; Rohrbach JM; Schnichels S
Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
[TBL] [Abstract][Full Text] [Related]
33. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.
Yang H; Jager MJ; Grossniklaus HE
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2835-42. PubMed ID: 20089875
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
[TBL] [Abstract][Full Text] [Related]
35. Vasculogenic mimicry in malignant mesothelioma: an experimental and immunohistochemical analysis.
Pulford E; Hocking A; Griggs K; McEvoy J; Bonder C; Henderson DW; Klebe S
Pathology; 2016 Dec; 48(7):650-659. PubMed ID: 27956272
[TBL] [Abstract][Full Text] [Related]
36. Vasculogenic Mimicry-An Overview.
Marques Dos Reis E; Vieira Berti F
Methods Mol Biol; 2022; 2514():3-13. PubMed ID: 35771413
[TBL] [Abstract][Full Text] [Related]
37. The involvement of apoptosis in melanoma vasculogenic mimicry.
Vartanian AA; Burova OS; Stepanova EV; Baryshnikov AY
Melanoma Res; 2007 Feb; 17(1):1-8. PubMed ID: 17235236
[TBL] [Abstract][Full Text] [Related]
38. Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression.
Bhattacharyya S; Mitra D; Ray S; Biswas N; Banerjee S; Majumder B; Mustafi SM; Murmu N
Microvasc Res; 2019 Jan; 121():52-62. PubMed ID: 30381268
[TBL] [Abstract][Full Text] [Related]
39. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
40. Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice.
Zeng Q; Wu Z; Duan H; Jiang X; Tu T; Lu D; Luo Y; Wang P; Song L; Feng J; Yang D; Yan X
Protein Cell; 2014 Jun; 5(6):445-56. PubMed ID: 24756564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
